Acadia Healthcare (ACHC) Expected to Announce Quarterly Earnings on Tuesday

Acadia Healthcare (NASDAQ:ACHC) will likely be announcing its Q2 2026 results before the market opens on Tuesday, July 28th. Analysts expect the company to announce earnings of $0.33 per share and revenue of $844.1920 million for the quarter. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Parties can find conference call details on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Wednesday, July 29, 2026 at 9:00 AM ET.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. During the same period in the previous year, the firm earned $0.40 earnings per share. Acadia Healthcare’s revenue for the quarter was up 7.6% compared to the same quarter last year. On average, analysts expect Acadia Healthcare to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $34.51 on Monday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare has a 1-year low of $11.43 and a 1-year high of $35.83. The firm has a market capitalization of $3.17 billion, a price-to-earnings ratio of -2.82, a price-to-earnings-growth ratio of 11.51 and a beta of 0.64. The stock has a fifty day simple moving average of $27.64 and a 200 day simple moving average of $23.24.

Institutional Investors Weigh In On Acadia Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Invesco Ltd. grew its holdings in shares of Acadia Healthcare by 58.7% during the 4th quarter. Invesco Ltd. now owns 727,846 shares of the company’s stock valued at $10,328,000 after acquiring an additional 269,140 shares in the last quarter. Wellington Management Group LLP boosted its position in Acadia Healthcare by 24.9% during the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. SummitTX Capital L.P. acquired a new stake in Acadia Healthcare during the fourth quarter valued at $821,000. Toronto Dominion Bank purchased a new position in Acadia Healthcare in the fourth quarter valued at about $5,880,000. Finally, Twinbeech Capital LP purchased a new position in Acadia Healthcare in the fourth quarter valued at about $1,182,000.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Barclays boosted their price objective on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, April 30th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research report on Friday, June 12th. Royal Bank Of Canada boosted their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. UBS Group upped their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Finally, KeyCorp raised their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $28.69.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.